David Badawi Biography and Net Worth

David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease.

He also oversees the preclinical and clinical development of each of the company’s products. In addition to building Sight Sciences and helping to bring multiple innovative technologies to the operating room and the ophthalmology clinic, David runs a busy referral and surgical practice in the Chicago suburbs. David received a BS in Microbiology from the University of Maryland and an MD from Georgetown University. He completed his residency in ophthalmology at the Jules Stein Eye Institute at UCLA and a cornea fellowship at Emory University.

What is David Badawi's net worth?

The estimated net worth of David Badawi is at least $10.51 million as of April 2nd, 2026. Dr. Badawi owns 1,990,290 shares of Sight Sciences stock worth more than $10,508,731 as of May 7th. This net worth estimate does not reflect any other assets that Dr. Badawi may own. Learn More about David Badawi's net worth.

How do I contact David Badawi?

The corporate mailing address for Dr. Badawi and other Sight Sciences executives is 4040 CAMPBELL AVE SUITE 100, MENLO PARK CA, 94025. Sight Sciences can also be reached via phone at 877-266-1144 and via email at [email protected]. Learn More on David Badawi's contact information.

Has David Badawi been buying or selling shares of Sight Sciences?

During the past quarter, David Badawi has sold $28,424.64 in Sight Sciences stock. Most recently, David Badawi sold 8,168 shares of the business's stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $3.48, for a transaction totalling $28,424.64. Following the completion of the sale, the chief technology officer now directly owns 1,990,290 shares of the company's stock, valued at $6,926,209.20. Learn More on David Badawi's trading history.

Who are Sight Sciences' active insiders?

Sight Sciences' insider roster includes David Badawi (Founder & Chief Technology Officer), Alison Bauerlein (CFO), Staffan Encrantz (Director), Jesse Selnick (CFO), and Brenton Taylor (Executive Vice President, Operations and R&D). Learn More on Sight Sciences' active insiders.

Are insiders buying or selling shares of Sight Sciences?

In the last year, insiders at the sold shares 30 times. They sold a total of 307,648 shares worth more than $1,746,086.49. The most recent insider tranaction occured on April, 6th when CFO James Rodberg sold 7,231 shares worth more than $25,670.05. Insiders at Sight Sciences own 30.9% of the company. Learn More about insider trades at Sight Sciences.

Information on this page was last updated on 4/6/2026.